Coronavirus: Commission approves new contract for a potential COVID-19 vaccine with Novavax

European Commission Press release Brussels, 04 Aug 2021 Today, the European Commission has approved its seventh Advanced Purchase Agreement (APA) with a pharmaceutical company to ensure access to a potential vaccine against COVID-19 in Q4 of 2021 and in 2022.

Other news